Drug · DIN 02411652
ROSUVASTATIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 13, 2024; first marketed October 23, 2013.
- Drug Identification Number (DIN)
- 02411652
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rosuvastatin C10AA07
- Class
- Human
- Record last updated
- September 8, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROSUVASTATIN (ROSUVASTATIN CALCIUM) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 31, 2023: NOC 31347Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
- January 31, 2019: NOC 21813Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- September 11, 2013: NOC 14726Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ROSUVASTATIN
- DIN 02405628 · Marketed
- DIN 02405636 · Marketed
- DIN 02405644 · Marketed
- DIN 02405652 · Marketed
- DIN 02411628 · Marketed
- DIN 02411636 · Marketed
- DIN 02411644 · Marketed
- DIN 02562863 · Marketed
- DIN 02562871 · Marketed
- DIN 02562898 · Marketed
- DIN 02562901 · Marketed
- DIN 02389037 · Cancelled Post Market
- DIN 02389045 · Cancelled Post Market
- DIN 02389053 · Cancelled Post Market
- DIN 02389061 · Cancelled Post Market
- DIN 02389355 · Cancelled Pre Market
- DIN 02389401 · Cancelled Pre Market
- DIN 02389428 · Cancelled Pre Market
- DIN 02389436 · Cancelled Pre Market
- DIN 02433125 · Cancelled Pre Market